Q1 EPS Estimates for Acadia Healthcare Cut by Zacks Research

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at Zacks Research reduced their Q1 2026 earnings per share (EPS) estimates for Acadia Healthcare in a report released on Wednesday, March 11th. Zacks Research analyst Team now anticipates that the company will earn $0.28 per share for the quarter, down from their previous forecast of $0.29. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q3 2026 earnings at $0.52 EPS, Q4 2026 earnings at $0.19 EPS, Q1 2027 earnings at $0.24 EPS, Q2 2027 earnings at $0.44 EPS, Q3 2027 earnings at $0.52 EPS, Q4 2027 earnings at $0.34 EPS and FY2028 earnings at $1.67 EPS.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.04. The company had revenue of $821.46 million for the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. Acadia Healthcare’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS.

A number of other equities analysts have also recently commented on ACHC. Guggenheim lowered their price target on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, February 23rd. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. Royal Bank Of Canada upped their target price on Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, February 26th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Finally, UBS Group lifted their price objective on shares of Acadia Healthcare from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $21.15.

Acadia Healthcare Stock Down 5.0%

NASDAQ ACHC opened at $23.89 on Thursday. The company has a market cap of $2.20 billion, a price-to-earnings ratio of -1.96, a PEG ratio of 8.49 and a beta of 0.74. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $31.04. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. The company has a 50 day moving average of $16.41 and a 200-day moving average of $18.73.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Allworth Financial LP raised its position in Acadia Healthcare by 676.4% during the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN grew its holdings in Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares during the last quarter. Bayforest Capital Ltd purchased a new position in Acadia Healthcare during the 4th quarter valued at about $52,000. Finally, Hantz Financial Services Inc. increased its stake in shares of Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after buying an additional 1,822 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.